News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
394 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (5)
2 (321)
3 (345)
4 (310)
5 (394)
6 (122)
7 (3)
8 (3)
9 (242)
10 (360)
11 (259)
12 (398)
13 (145)
14 (4)
15 (16)
16 (326)
17 (318)
18 (251)
19 (262)
20 (127)
21 (4)
22 (5)
23 (228)
24 (302)
25 (222)
26 (289)
27 (144)
28 (1)
29 (3)
30 (42)
31 (252)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Policy
Incyte Announces European Commission Approval of Jakavi® (ruxolitinib) as the First Post-Steroid Treatment for Acute and Chronic Graft-Versus-Host Disease
Incyte announced the European Commission has approved Jakavi® for the treatment of patients aged 12 years and older with acute or chronic GVHD who have inadequate response to corticosteroids or other systemic therapies.
May 5, 2022
·
10 min read
Biopharmaceutical Contract Manufacturing Market is anticipated to progress at a CAGR of 10.5% to reach US$ 18.7 Billion by 2029.
Reduced overall time to market investment in new drugs, access to expensive technologies, and greater flexibility are some advantages offered by biopharmaceutical manufacturing companies.
May 5, 2022
·
3 min read
Breast Esthetic Surgery Market: Rising prevalence of breast cancer is fuelling growth of the market
Albany NY, United States: The breast is a naturally a significant structural part of the women’s body which personates esthetic, a functional role, and anatomical impresses.
May 5, 2022
·
5 min read
Cystoscope Market: Rise in incidences of urinary tract infections to drive the market
Albany NY, United States: Cystoscope is a medical device that has a thin tube with camera and a light source at the tip of device.
May 5, 2022
·
5 min read
Peptide Cancer Vaccine Market: Increase in the Pool of Cancer Patients to Drive the Market
Albany NY, United States: Vaccines are biological products which stimulate the immune system of the body to protect the body against foreign substances.
May 5, 2022
·
5 min read
Patient Lateral Transfer Market is expected to reach US$ 519.3 Million by 2030.
The likelihood of patients moving and getting lifted from stretchers or bed causing back injuries, strain to caregivers and healthcare workers owing to forceful exertion, repetitive movement, and awkward posture can’t be ruled out.
May 5, 2022
·
3 min read
Medical Cannula Market at a high 7.3% CAGR to reach a valuation of US$ 783.5 Million by 2030.
According to a new market study by Future Market Insights, the medical cannula market is forecasted to expand at a healthy CAGR of 7% in 2020.
May 5, 2022
·
4 min read
BioMidwest
Clearside Biomedical Poster Presentation at ARVO 2022 Annual Meeting Demonstrates Versatility of Suprachoroidal Delivery Technology
Clearside Biomedical, Inc. announced that several poster presentations were delivered on Clearside’s proprietary suprachoroidal delivery platform, XIPERE®, and gene therapy delivery utilizing Clearside’s SCS Microinjector® at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting.
May 5, 2022
·
9 min read
Pharm Country
BioXcel Therapeutics to Present at Three Upcoming Investor Conferences
BioXcel Therapeutics, Inc. today announced that Vimal Mehta, Ph.D., Founder and Chief Executive Officer, will participate in three upcoming investor conferences.
May 5, 2022
·
4 min read
Drug Development
Clover’s Bivalent COVID-19 Vaccine Candidate Demonstrates Broad Neutralization Against Omicron and Other Variants of Concern
Clover Biopharmaceuticals, Ltd. announced new promising data from a preclinical study on Clover’s bivalent vaccine candidate, which combines the trimeric spike antigens from the original SARS-CoV-2 strain and the Omicron variant.
May 5, 2022
·
6 min read
Previous
11 of 40
Next